The elevated levels of IL-10 and suppressed levels of IFN-γ and IL-17A play key roles in therapeutic effect in RA considering that these cytokines can further activate or inhibit various types of immune cells such as B cells, Th2 cells, and neutrophils. This evidence concerns the gene IL10 and rheumatoid arthritis.